0.5304
Schlusskurs vom Vortag:
$0.557
Offen:
$0.56
24-Stunden-Volumen:
1.78M
Relative Volume:
2.90
Marktkapitalisierung:
$45.70M
Einnahmen:
$2.24M
Nettoeinkommen (Verlust:
$-136.67M
KGV:
-0.2316
EPS:
-2.29
Netto-Cashflow:
$-102.08M
1W Leistung:
-5.08%
1M Leistung:
+5.22%
6M Leistung:
-69.16%
1J Leistung:
-82.78%
Century Therapeutics Inc Stock (IPSC) Company Profile
Firmenname
Century Therapeutics Inc
Sektor
Branche
Telefon
215-981-4000
Adresse
25 N 38TH STREET, 11TH FLOOR, PHILADELPHIA
Vergleichen Sie IPSC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
IPSC
Century Therapeutics Inc
|
0.5304 | 48.15M | 2.24M | -136.67M | -102.08M | -2.29 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Century Therapeutics Inc Stock (IPSC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-08 | Eingeleitet | Rodman & Renshaw | Buy |
2023-08-28 | Herabstufung | JP Morgan | Overweight → Neutral |
2022-12-27 | Eingeleitet | Chardan Capital Markets | Buy |
2022-10-31 | Eingeleitet | Guggenheim | Buy |
2022-10-10 | Eingeleitet | Canaccord Genuity | Buy |
2022-05-23 | Eingeleitet | H.C. Wainwright | Buy |
2022-05-12 | Eingeleitet | William Blair | Mkt Perform |
2021-07-13 | Eingeleitet | BofA Securities | Buy |
2021-07-13 | Eingeleitet | JP Morgan | Overweight |
2021-07-13 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Century Therapeutics Inc Aktie (IPSC) Neueste Nachrichten
Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN
Q2 EPS Estimate for Century Therapeutics Raised by Analyst - Defense World
Brokers Issue Forecasts for IPSC Q1 Earnings - Defense World
Century Therapeutics Announces Two Upcoming Presentations at the EULAR 2025 Congress - GlobeNewswire
Chardan Capital Issues Optimistic Forecast for IPSC Earnings - Defense World
Leerink Partnrs Has Negative Forecast for IPSC Q2 Earnings - Defense World
Century Therapeutics Reports Strong Q1 2025 Earnings - TipRanks
Century Therapeutics Reports Positive Q1 2025 Results and Advances in Cell Therapy Pipeline - MSN
Chardan Trims Price Target on Century Therapeutics to $6 From $7, Maintains Buy Rating - marketscreener.com
Chardan Capital Lowers Century Therapeutics (NASDAQ:IPSC) Price Target to $6.00 - Defense World
Chardan Capital Lowers Price Target for Century Therapeutics (IP - GuruFocus
Chardan Capital Lowers Price Target for Century Therapeutics (IPSC) | IPSC Stock News - GuruFocus
Century Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times
Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates - sharewise
Century Therapeutics Expands iPSC Cell Therapy to Europe as Q1 Revenue Surges to $109M - Stock Titan
Marshall Wace LLP Purchases New Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
JPMorgan Chase & Co. Buys 91,468 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
A closer look at Century Therapeutics Inc (IPSC)’s stock price trends - uspostnews.com
Geode Capital Management LLC Acquires 23,413 Shares of Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Century Therapeutics to Showcase Promising Cell Therapy Data at ASGCT Annual Meeting - MSN
Century Therapeutics, Inc. (IPSC) May Report Negative Earnings: Know the Trend Ahead of Q1 Release - Yahoo Finance
Century Therapeutics (IPSC) Expected to Announce Earnings on Thursday - Defense World
An Analysis of Century Therapeutics Inc (IPSC)’s Potential Price Growth - knoxdaily.com
Renaissance Technologies LLC Boosts Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Market Insight: Century Therapeutics Inc (IPSC)’s Notable Drop, Closing at 0.50 - DWinneX
Century Therapeutics to Present Preclinical Data at ASGCT 28th Annual Meeting on Novel iPSC-Derived Cell Therapies for Autoimmune Diseases and Cancer - Nasdaq
Century Therapeutics Announces Two Upcoming Presentations at the ASGCT 28th Annual Meeting - GlobeNewswire
Century Therapeutics Reveals Groundbreaking Cancer-Fighting Cell Therapy Data at Major Scientific Conference - Stock Titan
IPSCCentury Therapeutics, Inc. Latest Stock News & Market Updates - Stock Titan
Is it possible to buy Century Therapeutics Inc(IPSC) shares at a good price now? - uspostnews.com
Century Therapeutics Inc (IPSC): A Sitting Duck With -825.93% Upside Potential - Stocksregister
H.C. Wainwright maintains Buy rating on Century Therapeutics stock - Investing.com
Century Therapeutics Inc (IPSC)’s financial ratios: A comprehensive overview - DWinneX
H.C. Wainwright maintains Buy rating on Century Therapeutics stock By Investing.com - Investing.com UK
Century Therapeutics Inc [IPSC] Stock sold by Insider Pfeiffenberger Brent for $1375.0 - knoxdaily.com
Century Therapeutics Hosts Live Fireside Chat on Groundbreaking Cell Therapy Advances - MSN
Century Therapeutics to Host Live Chat on Preclinical Cell Therapy Programs Targeting Autoimmune Diseases and Cancer - Nasdaq
Century Therapeutics to Host Live Fireside Chat Focused on - GlobeNewswire
Century Therapeutics Unveils Next-Gen Cell Therapy Pipeline for Cancer and Autoimmune | IPSC Stock News - Stock Titan
American Century Companies Inc. Buys Shares of 105,337 Sangamo Therapeutics, Inc. (NASDAQ:SGMO) - Defense World
American Century Companies Inc. Buys 24,153 Shares of Trevi Therapeutics, Inc. (NASDAQ:TRVI) - Defense World
American Century Companies Inc. Purchases 12,162 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World
American Century Companies Inc. Invests $231,000 in Summit Therapeutics Inc. (NASDAQ:SMMT) - Defense World
American Century Companies Inc. Buys 12,295 Shares of Fate Therapeutics, Inc. (NASDAQ:FATE) - Defense World
Sei Investments Co. Purchases New Stake in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Bought by American Century Companies Inc. - Defense World
American Century Companies Inc. Invests $570,000 in Axsome Therapeutics, Inc. (NASDAQ:AXSM) - Defense World
American Century Companies Inc. Boosts Holdings in C4 Therapeutics, Inc. (NASDAQ:CCCC) - Defense World
American Century Companies Inc. Acquires 4,547 Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) - Defense World
American Century Companies Inc. Purchases 13,916 Shares of Verve Therapeutics, Inc. (NASDAQ:VERV) - Defense World
American Century Companies Inc. Has $696,000 Stock Holdings in Voyager Therapeutics, Inc. (NASDAQ:VYGR) - Defense World
Finanzdaten der Century Therapeutics Inc-Aktie (IPSC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):